Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Hair loss needs more research for better treatments.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Finasteride safely lowers DHT levels without affecting testosterone.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Early hair loss may indicate risk of insulin resistance.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Multiple treatments work best for hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.